

| Catalog No. | HT315023 | ||||
|---|---|---|---|---|---|
| Description |
Anti-Parkin Recombinant Antibody (N136A/18) (HT315023) is a mouse monoclonal antibody detecting PRKN in IHC, WB.
Highlights
|
||||
| Applications | IHC, WB | ||||
| Host species | Mouse | ||||
| Clonality | Monoclonal | ||||
| Isotype | IgG2a, kappa | ||||
| Clone ID | N136A/18 | ||||
| Target | Parkin, PARK2, Parkinson juvenile disease protein 2, E3 ubiquitin-protein ligase parkin, Parkin RBR E3 ubiquitin-protein ligase, PRKN, Parkinson disease protein 2 | ||||
| Endotoxin level | < 10 EU/mg as determined by LAL method. | ||||
| Purity | >95% as determined by SDS-PAGE. | ||||
| Purification | Protein A/G purified from cell culture supernatant. | ||||
| RRID | Anti-Parkin Antibody (N136A/18) (abinScience Cat# HT315023, RRID:AB_3728022) |
||||
| Form | Liquid | ||||
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||
| Product Usage Information |
| ||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. | ||||
| Background | E3 ubiquitin-protein ligase parkin (PRKN) is a ~51 kDa protein. Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Substrates include SYT11 and VDAC1. Other substrates are BCL2, CCNE1, GPR37, RHOT1/MIRO1, MFN1, MFN2, STUB1, SNCAIP, SEPTIN5, TOMM20, USP30, ZNF746, MIRO1 and AIMP2. Mediates monoubiquitination as well as 'Lys-6', 'Lys-11', 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context. Participates in the removal and/or detoxification of abnormally folded or damaged protein by mediating 'Lys-63'-linked polyubiquitination of misfolded proteins such as PARK7: 'Lys-63'-linked polyubiquitinated misfolded proteins are then recognized by HDAC6, leading to their recruitment to aggresomes, followed by degradation. 1. Wang, C. et al. (2018) Nature communications 9, 81. PMID: 29311685 2. Ham, SJ. et al. (2020) Proceedings of the National Academy of Sciences of the United States of America 117, 4281-4291. PMID: 32047033 3. Shiba-Fukushima, K. et al. (2014) PLoS genetics 10, e1004861. PMID: 25474007 4. Kuroda, Y. et al. (2012) Human molecular genetics 21, 991-1003. PMID: 22082830 5. Yun, J. et al. (2014) eLife 3, e01958. PMID: 24898855 | ||||
| Note | For research use only. |

SDS-PAGE for Anti-Parkin Antibody (N136A/18)
Contact us for custom quotes, bulk requests and any other issues.
Mail: [email protected]


Quick access
Contact Us
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский